Supersaturated Oxygen (SSO2) Therapy in STEMI Treatments
-
29mPart 3 | Session 3 Questions and Answers
-
3m 38sPart 4 | Session 1 Introduction
-
11m 1sPart 4 | Session 2 Heart Failure Epidemic in STEMI
-
45m 2sPart 4 | Session 3 Fireside Chat
-
4m 32sPart 1 | Session 1 Why is Infarct Size Reduction Important
-
7m 22sPart 1 | Session 2 Impact of Microvascular Obstruction
-
5m 51sPart 1 | Session 3 What is SSO2 Therapy
-
11m 26sPart 1 | Session 4 Infarct Size and Clinical Outcomes
-
7m 22sPart 1 | Session 5 SSO2 Therapy and Infarct Size Reduction
-
20m 59sPart 1 | Session 6 Questions and Answers
-
1m 4sPart 2 | Session 1 Current State of STEMI Care
-
10m 41sPart 2 | Session 2 Evolution of STEMI Treatment
-
2m 44sPart 2 | Session 3 SSO2 Mechanism of Action
-
6m 46sPart 2 | Session 4 Clinical Results of SSO2 Therapy with Case Presentation
-
9m 1sPart 2 | Session 5 Case Presentation by Dr A Schäfer
-
24m 36sPart 2 | Session 6 Questions and Answers
-
2m 49sPart 3 | Session 1 Introduction
Despite advances in reperfusion with primary stenting, progress in STEMI outcomes has stalled over the past 20 years. With 90% of coronary blood flow in the capillaries, the answer might be in the microvasculature. TherOx SSO2 Therapy is the first FDA approved therapy shown to significantly reduce the infarct size in STEMI patients.
During this series of webinars on Supersaturated Oxygen (SSO2) Therapy, our faculty of renowned international experts will discuss and dissect the mechanisms and data around this promising new therapy for STEMI patients.
Key Objectives
- Understand how SSO2 Therapy works
- Hear about trends in STEMI treatment
- Explore the role of microvascular obstruction and infarct size in outcomes
- Understand the science behind SSO2 Therapy
Target Audience
This series is designed for the entire cardiology community:
- Interventional Cardiologists
- Cardiologists
- Clinical Fellows and Trainees
More from this programme
Part 1
Supersaturated Oxygen Therapy (SSO2): The Next Frontier in STEMI Treatment
Part 2
SSO2 Therapy in STEMI to Reduce Infarct Size: A Conversation with Global Thought Leaders
Part 3
Infarct Size, Microvascular Obstruction and Outcomes in STEMI: An Expert Panel Discussion
Part 4
Transforming STEMI Care: Bridging Interventional and Heart Failure Cardiology to Improve Patient Outcomes
This engaging session features the collaborative efforts of interventional and heart failure cardiologists in revolutionizing the management of ST-Elevation Myocardial Infarction (STEMI) and its impact on heart failure. Through a dynamic fireside chat format, our esteemed panelists will explore groundbreaking approaches and advancements that are reshaping STEMI care.
Faculty Biographies
Suzanne de Waha
Dr Suzanne de Waha works at University Heart Center, Luebeck, DE.
Her main focus is acute myocardial infarction (STEMI + NSTEMI), cardiac imaging including CMR, cardiogenic shock, assist devices, interventional cardiology and structural heart disease including TAVI.
Dr de Waha has >150 publications in peer-reviewed, international high-ranked journals.